KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy - Trinka, Eugen; Pohlmann-Eden, Bernd (Journal of neurology, neurosurgery, and psychiatry, 2013)
Gesehen am: 18.03.2015